Could Diabetes Drugs Cut Parkinson's Risk?
A new study suggests that medications used to treat diabetes may lower the risk for developing Parkinson’s disease. According to researchers, this discovery could lead to new prevention strategies and treatment options for the neurological disorder.
Researchers at the University of Bergen in Norway analyzed more than 100 million drug prescriptions from the Norwegian Prescription Database. They found that people who used glitazones (GTZs), also called thiazolidinediones, for type 2 diabetes have a 28 percent lower risk for Parkinson’s than diabetes patients who use metformin.
Previous studies have investigated the link between GTZs and reduced Parkinson’s risk, but results have been mixed. These recent findings were published in the journal Movement Disorders.